Target intelligence / Profile preview

Novel readthrough transcript, antisense to PITRM1

Molecular classification: Long non-coding RNA (lncRNA)

Overview

Novel readthrough transcript, antisense to PITRM1" (ENSG00000278419, also known by alias AL451164.2) is a long non-coding RNA (lncRNA) gene identified in humans that is transcribed in the antisense direction relative to the PITRM1 gene[1][5]. It is classified as a lncRNA and does not encode a conventional protein. Its biological function, disease associations, or potential as a therapeutic target have not been well characterized in the scientific literature to date[5]. There is no evidence that it serves as a receptor, enzyme, transporter, or other traditional druggable target class.

Other names: AL451164.2

Biological functions

Other (non-coding RNA; specific biological function is not established)

Disease associations

Other (no current evidence of a direct disease association or role as a biomarker/target)

Beyond the preview

Go deeper on Novel readthrough transcript, antisense to PITRM1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel readthrough transcript, antisense to PITRM1.

Explore the full profile